MoneyWorks4Me

Natco Pharma submits analyst meet intimation

10 Feb 2025 Evaluate
Further to earlier intimation dated 3rd February, 2025, Natco Pharma has informed that the Earnings Call with Investors / Analysts on Thursday, the 13th February, 2025 at 11:00 AM IST has been preponed to Thursday, the 13th February, 2025 at 10:00 AM IST to discuss the Unaudited Financial Results of the Company for the quarter ended 31st December, 2024.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..